2m 2m 2m 2m 2m 2m 2m
GH RSRCH (GHRS)
NASDAQ
$28.08+$0.010 (+0.04%)
Price as of Aug 03, 2026 4:26 AM EDT- $1.7BMarket Cap
- 104.29%1-Year Change
- BiotechnologyIndustry
GH RSRCH (GHRS)
$28.08+$0.010 (+0.04%)
GHRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.07 | ||
Change | -$0.31 (-1.09%) | ||
Open | $28.50 | ||
High | $28.85 | ||
Low | $27.86 | ||
Previous Close | $28.38 | ||
Volume | 177,845 | ||
30-Day Average Volume | 276,939 | ||
1-Week Change | 2.90% | ||
1-Month Change | 4.43% | ||
1-Year Change | 104.29% | ||
3-Year Change | 113.46% | ||
5-Year Change | 42.49% | ||
Fundamentals | |||
Shares Outstanding | 62.0M | ||
Total Assets | $288.2M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue